These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 24249637

  • 1. Lysophosphatidic acid induces vasodilation mediated by LPA1 receptors, phospholipase C, and endothelial nitric oxide synthase.
    Ruisanchez É, Dancs P, Kerék M, Németh T, Faragó B, Balogh A, Patil R, Jennings BL, Liliom K, Malik KU, Smrcka AV, Tigyi G, Benyó Z.
    FASEB J; 2014 Feb; 28(2):880-90. PubMed ID: 24249637
    [Abstract] [Full Text] [Related]

  • 2. LPA1 receptor-mediated thromboxane A2 release is responsible for lysophosphatidic acid-induced vascular smooth muscle contraction.
    Dancs PT, Ruisanchez É, Balogh A, Panta CR, Miklós Z, Nüsing RM, Aoki J, Chun J, Offermanns S, Tigyi G, Benyó Z.
    FASEB J; 2017 Apr; 31(4):1547-1555. PubMed ID: 28069828
    [Abstract] [Full Text] [Related]

  • 3. LPA induces osteoblast differentiation through interplay of two receptors: LPA1 and LPA4.
    Liu YB, Kharode Y, Bodine PV, Yaworsky PJ, Robinson JA, Billiard J.
    J Cell Biochem; 2010 Mar 01; 109(4):794-800. PubMed ID: 20069565
    [Abstract] [Full Text] [Related]

  • 4. Adiponectin stimulates production of nitric oxide in vascular endothelial cells.
    Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ.
    J Biol Chem; 2003 Nov 07; 278(45):45021-6. PubMed ID: 12944390
    [Abstract] [Full Text] [Related]

  • 5. Syringaresinol causes vasorelaxation by elevating nitric oxide production through the phosphorylation and dimerization of endothelial nitric oxide synthase.
    Chung BH, Kim S, Kim JD, Lee JJ, Baek YY, Jeoung D, Lee H, Choe J, Ha KS, Won MH, Kwon YG, Kim YM.
    Exp Mol Med; 2012 Mar 31; 44(3):191-201. PubMed ID: 22170035
    [Abstract] [Full Text] [Related]

  • 6. Lysophosphatidic acid and receptor-mediated activation of endothelial nitric-oxide synthase.
    Kou R, Igarashi J, Michel T.
    Biochemistry; 2002 Apr 16; 41(15):4982-8. PubMed ID: 11939794
    [Abstract] [Full Text] [Related]

  • 7. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
    Park SJ, Lee KP, Kang S, Chung HY, Bae YS, Okajima F, Im DS.
    Cell Signal; 2013 Nov 16; 25(11):2147-54. PubMed ID: 23838008
    [Abstract] [Full Text] [Related]

  • 8. Lysophosphatidic acid acts on LPA1 receptor to increase H2 O2 during flow-induced dilation in human adipose arterioles.
    Chabowski DS, Kadlec AO, Ait-Aissa K, Hockenberry JC, Pearson PJ, Beyer AM, Gutterman DD.
    Br J Pharmacol; 2018 Nov 16; 175(22):4266-4280. PubMed ID: 30153326
    [Abstract] [Full Text] [Related]

  • 9. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.
    Chen M, Towers LN, O'Connor KL.
    Am J Physiol Cell Physiol; 2007 May 16; 292(5):C1927-33. PubMed ID: 17496233
    [Abstract] [Full Text] [Related]

  • 10. Autotaxin and LPA receptors represent potential molecular targets for the radiosensitization of murine glioma through effects on tumor vasculature.
    Schleicher SM, Thotala DK, Linkous AG, Hu R, Leahy KM, Yazlovitskaya EM, Hallahan DE.
    PLoS One; 2011 May 16; 6(7):e22182. PubMed ID: 21799791
    [Abstract] [Full Text] [Related]

  • 11. Nitric oxide signaling via nuclearized endothelial nitric-oxide synthase modulates expression of the immediate early genes iNOS and mPGES-1.
    Gobeil F, Zhu T, Brault S, Geha A, Vazquez-Tello A, Fortier A, Barbaz D, Checchin D, Hou X, Nader M, Bkaily G, Gratton JP, Heveker N, Ribeiro-da-Silva A, Peri K, Bard H, Chorvatova A, D'Orléans-Juste P, Goetzl EJ, Chemtob S.
    J Biol Chem; 2006 Jun 09; 281(23):16058-67. PubMed ID: 16574649
    [Abstract] [Full Text] [Related]

  • 12. Lysophosphatidic acid-induced vascular neointimal formation in mouse carotid arteries is mediated by the matricellular protein CCN1/Cyr61.
    Hao F, Zhang F, Wu DD, An D, Shi J, Li G, Xu X, Cui MZ.
    Am J Physiol Cell Physiol; 2016 Dec 01; 311(6):C975-C984. PubMed ID: 27760754
    [Abstract] [Full Text] [Related]

  • 13. Lysophosphatidic acid receptors 1 and 2 play roles in regulation of vascular injury responses but not blood pressure.
    Panchatcharam M, Miriyala S, Yang F, Rojas M, End C, Vallant C, Dong A, Lynch K, Chun J, Morris AJ, Smyth SS.
    Circ Res; 2008 Sep 12; 103(6):662-70. PubMed ID: 18703779
    [Abstract] [Full Text] [Related]

  • 14. Lysophosphatidic acid and its receptor LPA1 mediate carrageenan induced inflammatory pain in mice.
    Srikanth M, Chew WS, Hind T, Lim SM, Hay NWJ, Lee JHM, Rivera R, Chun J, Ong WY, Herr DR.
    Eur J Pharmacol; 2018 Dec 15; 841():49-56. PubMed ID: 30321532
    [Abstract] [Full Text] [Related]

  • 15. Lysophosphatidic acid regulates inflammation-related genes in human endothelial cells through LPA1 and LPA3.
    Lin CI, Chen CN, Lin PW, Chang KJ, Hsieh FJ, Lee H.
    Biochem Biophys Res Commun; 2007 Nov 30; 363(4):1001-8. PubMed ID: 17923111
    [Abstract] [Full Text] [Related]

  • 16. Role of lysophosphatidic acid receptor LPA2 in the development of allergic airway inflammation in a murine model of asthma.
    Zhao Y, Tong J, He D, Pendyala S, Evgeny B, Chun J, Sperling AI, Natarajan V.
    Respir Res; 2009 Nov 20; 10(1):114. PubMed ID: 19930563
    [Abstract] [Full Text] [Related]

  • 17. A549 cells as a model to study endogenous LPA1 receptor signaling and regulation.
    Carmona-Rosas G, Alfonzo-Méndez MA, Hernández-Espinosa DA, Romero-Ávila MT, García-Sáinz JA.
    Eur J Pharmacol; 2017 Nov 15; 815():258-265. PubMed ID: 28943105
    [Abstract] [Full Text] [Related]

  • 18. Lysophosphatidic acid (LPA) as a modulator of plasma membrane Ca2+-ATPase from basolateral membranes of kidney proximal tubules.
    Sant'Anna JF, Baldez VS, Razuck-Garrão NA, Lemos T, Diaz BL, Einicker-Lamas M.
    J Physiol Biochem; 2021 May 15; 77(2):321-329. PubMed ID: 33704695
    [Abstract] [Full Text] [Related]

  • 19. Differential targeting of lysophosphatidic acid LPA1, LPA2, and LPA3 receptor signalling by tricyclic and tetracyclic antidepressants.
    Olianas MC, Dedoni S, Onali P.
    Eur J Pharmacol; 2023 Nov 15; 959():176064. PubMed ID: 37758013
    [Abstract] [Full Text] [Related]

  • 20. Antidepressants activate the lysophosphatidic acid receptor LPA(1) to induce insulin-like growth factor-I receptor transactivation, stimulation of ERK1/2 signaling and cell proliferation in CHO-K1 fibroblasts.
    Olianas MC, Dedoni S, Onali P.
    Biochem Pharmacol; 2015 Jun 15; 95(4):311-23. PubMed ID: 25888927
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.